Toward Deciphering the Code to Aminergic G Protein-Coupled Receptor Drug Design

Chemistry and Biology

Volumn 15, Issue 4, 2008, Pages 343-353

  Tan, Edwin S ^a   Groban, Eli S ^a   Jacobson, Matthew P ^a   Scanlan, Thomas S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

CHEMBIO; SIGNALING

Indexed keywords

3 IODOTHYRONAMINE; 3-IODOTHYRONAMINE; G PROTEIN COUPLED RECEPTOR; THYRONINE DERIVATIVE; TRACE AMINE ASSOCIATED RECEPTOR 1; TRACE AMINE-ASSOCIATED RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CHEMISTRY; DRUG ANTAGONISM; DRUG DESIGN; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; PROTEIN BINDING; PROTEIN CONFORMATION; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DESIGN; PROTEIN BINDING; PROTEIN CONFORMATION; RATS; RECEPTORS, G-PROTEIN-COUPLED; STRUCTURE-ACTIVITY RELATIONSHIP; THYRONINES;

MUS; RATTUS;

EID: 41949112361     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2008.03.004     Document Type: Article

References (43)

1. Ballesteros J., and Weinstein H. Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25 (1995) 366-428
2. Ballesteros J., Jensen A., Liapakis G., Rasmussen S., Shi L., Gether U., and Javitch J. Activation of the β(2)-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J. Biol. Chem. 276 (2001) 29171-29177
3. Borowsky B., Adham N., Jones K., Raddatz R., Artymyshyn R., Ogozalek K., Durkin M., Lakhlani P., Bonini J., Pathirana S., et al. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 98 (2001) 8966-8971
4. Bunzow J., Sonders M., Arttamangkul S., Harrison L., Zhang G., Quigley D., Darland T., Suchland K., Pasumamula S., Kennedy J., et al. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60 (2001) 1181-1188
5. Cherezov V., Rosenbaum D.M., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Kuhn P., Weis W.I., Kobilka B.K., et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318 (2007) 1258-1265
6. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32 (2004) 1792-1797
7. Evers A., and Klabunde T. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the α1A adrenergic receptor. J. Med. Chem. 48 (2005) 1088-1097
8. Evers A., Hessler G., Matter H., and Klabunde T. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. J. Med. Chem. 48 (2005) 5448-5465
9. Gallicchio E., Zhang L.Y., and Levy R.M. The SGB/NP hydration free energy model based on the surface generalized Born solvent reaction field and novel nonpolar hydration free energy estimators. J. Comput. Chem. 23 (2002) 517-529
10. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 21 (2000) 90-113
11. Ghosh A., Rapp C., and Friesner R. Generalized Born model based on a surface integral formulation. J. Phys. Chem. B 112 (1998) 10983-10990
12. Hart M., Suchland K., Miyakawa M., Bunzow J., Grandy D., and Scanlan T. Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J. Med. Chem. 49 (2006) 1101-1112
13. Jacobson M., Kaminski G., Friesner R., and Rapp C. Force field validation using protein side chain prediction. J. Phys. Chem. B 106 (2002) 11673-11680
14. Jacobson M.P., Pincus D.L., Rapp C.S., Day T.J., Honig B., Shaw D.E., and Friesner R.A. A hierarchical approach to all-atom protein loop prediction. Proteins 55 (2004) 351-367
15. Jorgensen W., Maxwell D., and Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J. Am. Chem. Soc. 118 (1996) 11225-11236
16. Kaminski G., Friesner R., Tirado-Rives J., and Jorgensen W. Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. J. Phys. Chem. B 105 (2001) 6474-6487
17. Klabunde T., and Evers A. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects. ChemBioChem 6 (2005) 876-889
18. Klabunde T., and Hessler G. Drug design strategies for targeting G-protein-coupled receptors. ChemBioChem 3 (2002) 929-944
19. Kobilka B., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol. Sci. 28 (2007) 397-406
20. Liapakis G., Ballesteros J., Papachristou S., Chan W., Chen X., and Javitch J. The forgotten serine-a critical role for Ser-203(5.42) in ligand binding to and activation of the β(2)-adrenergic receptor. J. Biol. Chem. 275 (2000) 37779-37788
21. Liapakis G., Chan W., Papadokostaki M., and Javitch J. Synergistic contributions of the functional groups of epinephrine to its affinity and efficacy at the β(2) adrenergic receptor. Mol. Pharmacol. 65 (2004) 1181-1190
22. Lindemann L., Ebeling M., Kratochwil N., Bunzow J., Grandy D., and Hoener M. Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. Genomics 85 (2005) 372-385
23. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
24. Rasmussen S.G., Choi H.J., Rosenbaum D.M., Kobilka T.S., Thian F.S., Edwards P.C., Burghammer M., Ratnala V.R., Sanishvili R., Fischetti R.F., et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor. Nature 450 (2007) 383-387
25. Rosenbaum D.M., Cherezov V., Hanson M.A., Rasmussen S.G., Thian F.S., Kobilka T.S., Choi H.J., Yao X.J., Weis W.I., Stevens R.C., et al. GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318 (2007) 1266-1273
26. Scanlan T., Suchland K., Hart M., Chiellini G., Huang Y., Kruzich P., Frascarelli S., Crossley D., Bunzow J., Ronca-Testoni S., et al. 3-iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat. Med. 10 (2004) 638-642
27. Shi L., and Javitch J. The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 437-467
28. Shi L., Liapakis G., Xu R., Guarnieri F., Ballesteros J., and Javitch J. β(2) adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch. J. Biol. Chem. 277 (2002) 40989-40996
29. Snead A.N., Santos M.S., Seal R.P., Miyakawa M., Edwards R.H., and Scanlan T.S. Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem. Biol. 2 (2007) 390-398
30. Strader C., Sigal I., Candelore M., Rands E., Hill W., and Dixon R. Conserved aspartic-acid residue-79 and residue-113 of the β-adrenergic-receptor have different roles in receptor function. J. Biol. Chem. 263 (1988) 10267-10271
31. Strader C., Candelore M., Hill W., Sigal I., and Dixon R. Identification of two serine residues involved in agonist activation of the β-adrenergic-receptor. J. Biol. Chem. 264 (1989) 13572-13578
32. Strader C., Sigal I., and Dixon R. Structural basis of β-adrenergic-receptor function. FASEB J. 3 (1989) 1825-1832
33. Strader C., Fong T., Tota M., Underwood D., and Dixon R. Structure and function of G-protein coupled receptors. Annu. Rev. Biochem. 63 (1994) 101-132
34. Suryanarayana S., Daunt D., von Zastrow M., and Kobilka B. A point mutation in the seventh hydrophobic domain of the α-2-adrenergic-receptor increases its affinity for a family of β-receptor-antagonists. J. Biol. Chem. 266 (1991) 15488-15492
35. Swaminath G., Xiang Y., Lee T., Steenhuis J., Parnot C., and Kobilka B. Sequential binding of agonists to the β(2) adrenoceptor-kinetic evidence for intermediate conformational states. J. Biol. Chem. 279 (2004) 686-691
36. Tan E., Miyakawa M., Bunzow J., Grandy D., and Scanlan T. Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1. J. Med. Chem. 50 (2007) 2787-2798
37. Tota M.R., Candelore M.R., Dixon R.A., and Strader C.D. Biophysical and genetic analysis of the ligand-binding site of the β-adrenoceptor. Trends Pharmacol. Sci. 12 (1991) 4-6
38. Wainscott D., Little S., Yin T., Tu Y., Rocco V., He J., and Nelson D. Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J. Pharmacol. Exp. Ther. 320 (2007) 475-485
39. Wess J. Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol. Ther. 80 (1998) 231-264
40. Wieland K., Zuurmond H., Krasel C., Ijzerman A., and Lohse M. Involvement of Asn-293 in stereospecific agonist recognition and in activation of the β(2)-adrenergic receptor. Proc. Natl. Acad. Sci. USA 93 (1996) 9276-9281
41. Yao X., Parnot C., Deupi X., Ratnala V., Swaminath G., Farrens D., and Kobilka B. Coupling ligand structure to specific conformational switches in the β(2)-adrenoceptor. Nat. Chem. Biol. 2 (2006) 417-422
42. Zucchi R., Chiellini G., Scanlan T., and Grandy D. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 149 (2006) 967-978
43. Zuurmond H., Hessling J., Bluml K., Lohse M., and Ijzerman A. Study of interaction between agonists and Asn293 in helix VI of human β(2)-adrenergic receptor. Mol. Pharmacol. 56 (1999) 909-916